Research Paper Volume 16, Issue 9 pp 7774—7798
The identification of a N6-methyladenosin-modifed immune pattern to predict immunotherapy response and survival in urothelial carcinoma
Figure 3. The scatter plots (A–E) on the left illustrate the distribution of death events across risk scores derived from MPIGs. The heatmap (A–E) on the right displays the specific upregulation or downregulation of MPIGs expression across different risk groups.